Clinical Trial Update: S-1 Combined Cisplatin HIPEC for Palliative Operation Gastric Cancer of Stage IV Limited Peritoneal Metastasis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating S-1 combined with cisplatin HIPEC for palliative surgery in Stage IV gastric cancer with limited peritoneal metastasis;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Tang-Du Hospital | Conditions: Stage IV Gastric Cancer | Phase 2 | Status: UNKNOWN